Oct 15 (Reuters)-
Chordia Therapeutics
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to
Aug 31, 2026 Aug 31, 2025 Aug 31, 2027
LATEST YEAR-AGO COMPANY
RESULTS RESULTS FORECAST
Operating loss 1.47 loss 1.79 --
Recurring loss 1.45 loss 1.77 --
Net loss 1.46 loss 1.79 --
EPS loss 19.74 yen loss 26.03 yen --
Ann Div 0.00 yen 0.00 yen 0.00 yen
-Q2 div 0.00 yen 0.00 yen 0.00 yen
-Q4 div 0.00 yen 0.00 yen 0.00 yen
NOTE - Chordia Therapeutics.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T